DRSI ReStore! Energy’s media campaign targets NYC
BOCA RATON, Fla. — Diabetica Research Solutions is spreading the word about its diabetes energy formula with a new media program that targets the New York metropolitan area.
The targeted media program for DRSI ReStore! Energy — which now is available at Duane Reade and Rite Aid pharmacies in the area — supplements the brand’s national television campaign, includes high saturation local commercial spots on television and radio, and internet banner ads to appear specifically on Web pages viewed by people in New York and the surrounding area.
"By supplementing our national television schedule with a locally targeted multimedia strategy, we can increase awareness of the brand DRSI ReStore! Energy, and expand our reach to many millions of people with diabetes," said Michael Dugan, DRSI marketing director.
DRSI ReStore! Energy is available at Kroger, Winn-Dixie, Giant Eagle, CVS.com, USA Drugs, Navarro Discount Pharmacies and more.
Industry organizations join forces to dispute new FDA restrictions
COLORADO SPRINGS, Colo. Several organizations representing retailers and consumer healthcare product manufacturers want Congress to reverse a provision in the healthcare-reform act that would prohibit the use of flexible spending accounts to purchase over-the-counter medicines without a prescription.
The provision, part of the Patient Protection and Affordable Care Act, which President Obama signed into law in March, goes into effect Jan. 1. Organizations opposing the provision include the Global Market Development Center, a trade association representing suppliers, retailers and wholesalers of general merchandise, health, beauty and wellness products, as well as the National Association of Chain Drug Stores, the Consumer Healthcare Products Association and the National Grocers Association.
“The new FDA restrictions will add additional confusion [and] expense, and eliminate a benefit many consumers have come to depend upon to cost-effectively purchase medicines they need,” GMDC president and CEO Dave McConnell said in a statement. “Consumers depend on OTC medicines as a first line of defense for their families’ healthcare needs, and retail stores are in the business of providing remedies in an accessible, consumer-friendly way.”
Millions of J&J OTC allergy and pain meds recalled
NEW BRUNSWICK, N.J. Johnson & Johnson is recalling millions of packages of over-the-counter drugs for allergies and pain due to manufacturing problems, according to published reports.
The New York Times reported Tuesday that J&J would recall 4 million packages of cherry- and grape-flavored Children’s Benadryl (diphenhydramine) tablets for allergies and 800,000 bottles of children’s Motrin (ibuprofen), a pain drug.
The company told the Times that the recall was at the wholesale and retail level and would not affect drugs already purchased by consumers.